1. Home
  2. ABVX vs NEU Comparison

ABVX vs NEU Comparison

Compare ABVX & NEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • NEU
  • Stock Information
  • Founded
  • ABVX 2013
  • NEU 1887
  • Country
  • ABVX France
  • NEU United States
  • Employees
  • ABVX N/A
  • NEU N/A
  • Industry
  • ABVX
  • NEU Major Chemicals
  • Sector
  • ABVX
  • NEU Industrials
  • Exchange
  • ABVX Nasdaq
  • NEU Nasdaq
  • Market Cap
  • ABVX 6.7B
  • NEU 7.4B
  • IPO Year
  • ABVX N/A
  • NEU N/A
  • Fundamental
  • Price
  • ABVX $105.95
  • NEU $773.85
  • Analyst Decision
  • ABVX Buy
  • NEU
  • Analyst Count
  • ABVX 11
  • NEU 0
  • Target Price
  • ABVX $110.36
  • NEU N/A
  • AVG Volume (30 Days)
  • ABVX 1.0M
  • NEU 66.6K
  • Earning Date
  • ABVX 08-11-2025
  • NEU 10-30-2025
  • Dividend Yield
  • ABVX N/A
  • NEU 1.54%
  • EPS Growth
  • ABVX N/A
  • NEU 5.10
  • EPS
  • ABVX N/A
  • NEU 47.34
  • Revenue
  • ABVX $7,073,400.00
  • NEU $2,744,413,000.00
  • Revenue This Year
  • ABVX $6.80
  • NEU N/A
  • Revenue Next Year
  • ABVX N/A
  • NEU N/A
  • P/E Ratio
  • ABVX N/A
  • NEU $16.13
  • Revenue Growth
  • ABVX N/A
  • NEU N/A
  • 52 Week Low
  • ABVX $4.77
  • NEU $480.00
  • 52 Week High
  • ABVX $108.00
  • NEU $875.97
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 71.68
  • NEU 48.76
  • Support Level
  • ABVX $96.10
  • NEU $739.79
  • Resistance Level
  • ABVX $104.99
  • NEU $790.97
  • Average True Range (ATR)
  • ABVX 4.36
  • NEU 19.79
  • MACD
  • ABVX 0.42
  • NEU 3.10
  • Stochastic Oscillator
  • ABVX 89.44
  • NEU 69.20

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About NEU NewMarket Corp

NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.

Share on Social Networks: